Revisão sistemática: o uso de probióticos gera benefícios para pacientes em tratamento de doenças inflamatórias intestinais?
DOI:
https://doi.org/10.11606/issn.1679-9836.v102i3e-201379Keywords:
Probiotic, Treatment of inflammatory bowel, IBD, Lactobacillus, BifidobacteriumAbstract
Objectives: To review the literature that assesses whether the use of probiotics generates benefits for individuals with IBD and to describe the mechanisms of action of probiotics in the pathogenesis of inflammatory bowel disease. Methods: This is a study classified as a systematic review. The selected publications were submitted to the Jadad Scale criteria to assess methodological quality. 15 articles were selected. Results: Of the five clinical trials that used placebo, only 1 did not show benefits from the use of probiotic therapy. The remainder showed a reduction in signs and symptoms and acute phase reagents or induction of remission in the groups treated with probiotics compared to placebo. Conclusion: The present systematic review suggests that the use of probiotics is beneficial in patients with IBD.
Downloads
References
Bernstein CN, Eliakim A, Fedail S, Fried M, Gearry R, Goh K, et al. World gastroenterology organisation global guidelines inflammatory bowel disease. Journal of Clinical Gastroenterology. 2016;50 (10):803-818.
Goldman L, Schafer AL. Goldman cecil medicina. 24th ed. Rio de Janeiro: Elsevier; 2014. 344 p. 1 vol. ISBN: 978-85-352-6899-7.
ABCD: Como as bactérias intestinais interferem na DII [Internet]. São Paulo: Associação Brasileira de Colite Ulcerativa e Doença de Crohn; 2020 Mar 18 [cited 2020 May 21]. Available from: https://abcd.org.br/blog/artigos/como-as-bacterias-intestinais-interferem-na-dii/.
Williams NT. Probiotics. American Journal of Health-System Pharmacy. 2010 Mar 15;67(6):449-58.
Silva VA, Leão ER, Silva MJP. Assessment of quality of scientific evidence on musical Interventions in caring for cancer patients. Interface comunicação saúde educação. 2014 Feb 23.
Matsuoka K, Uemura Y, Kanai T, Kunisaki R, Suzuki Y, Yokoyama K, et al. Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. Digestive Diseases and Sciences. 2018;63(7):1910-1919.
Altun HK, Yıldız EA, Akın M. Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study. Turk J Gastroenterol. 2020 Nov 05;30(4):313-320.
Bjarnason I, Sission G, Hayee BH. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease. Inflammopharmacology. 2019 May 03;27(3):465–473.
Yoshimatsu Y, Yamada A, Furukawa R, Sono K, Osamura A, Nakamura K, et al. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World J Gastroenterol. 2020 Nov 05;21(19):5985–5994.
Yılmaz İ, Dolar ME, Özpınar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial. Turk J Gastroenterol. 2019;30(3):242-253.
Fan H, Du J, Liu X, Zheng W, Zhuang Z, Wang C, et al. Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease. Turk J Gastroenterol. 2018 Aug 01;30(8):680–685.
Palumbo VD, Romeo M, Gammazza A, Carini F, Damiani P, Damiano G, et al. The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Sep 13;160(3):372-377.
Tamaki H, Nakase H, Inoue S, Kawanami C, Itani T, Ohana M, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double‐blinded, placebo‐controlled multicenter trial. Dig Endosc. 2016;28(1):67-74.
Lan B, Yang F, Lu D, Lin Z. Specific immunotherapy plus Clostridium butyricum alleviates ulcerative colitis in patients with food allergy. Sci Rep. 2016 May 11; 6:255-87.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ana Clara Lemos Andrade Cunha, Marselli Taubner Mascarenhas, Sofia Oliveira de Melo, Ivone Catarina Ferreira
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
